Trial reportBioMed research international2026
A Pilot Study on the Short-Term Effects of an Electric Knee-Ankle-Foot Orthosis on Gait Performance and Physiological Cost Index in Patients With Hemiplegia: Influence of Initial Balance Ability Assessed by the Berg Balance Scale.
Trial report in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Gait impairment is one of the most disabling consequences of stroke and substantially limits functional independence. While traditional orthoses provide joint stabilization, they often restrict natural motion and lack adaptive support. This study is aimed at evaluating the short-term effects of an electric knee-ankle-foot orthosis (E-KAFO) on gait performance and energy efficiency in patients with hemiplegia and at assessing how baseline balance ability, measured using the Berg Balance Scale (BBS), influences outcomes. This pre-post intervention, nonrandomized study enrolled poststroke survivors (n = 22), who were stratified into high- (BBS > 45) and low- (BBS ≤ 45) balance groups (HBG and LBG, respectively). Participants underwent gait assessments under two conditions: body-powered condition (BP_C), to evaluate rehabilitation effects independently of the device, and E-KAFO_C, to assess short-term assistive efficacy immediately after device use. All assessments were conducted before and after a 3-week intervention comprising seven E-KAFO training sessions. The primary outcome was gait speed, measured using the 5-m walk test (5-mWT). The 3-min and 6-min walk tests (3-MWT and 6-MWT) and the physiological cost index (PCI) were also evaluated to assess gait endurance and energy efficiency. The 5-mWT and 3-MWT/6-MWT were performed in randomized order to minimize order-related bias. No standard rehabilitation-only control group was included. Assistive effects (E-KAFO_C) and rehabilitative effects (BP_C) were analyzed and reported separately. Two-way repeated measures analysis of variance was used to assess the effects of group, time, and their interaction. Significant improvements in gait speed and endurance were observed across both conditions, with the LBG showing greater relative gains postintervention. In the E-KAFO_C condition, the LBG demonstrated a 33.31% increase in 5-mWT speed and a 25.51% increase in 3-MWT distance. Notably, PCI decreased in both groups, although the reduction was significant only in the LBG. These findings underscore the distinction between the short-term assistive benefits of the E-KAFO and the rehabilitative improvements captured by BP_C outcomes, emphasizing that BP_C results serve as the primary indicator of rehabilitation effectiveness. Importantly, baseline balance ability assessed by the BBS influenced assistive and rehabilitative responses, supporting its relevance for patient stratification. Given the exploratory design and limited sample size, these findings are hypothesis-generating and require confirmation in larger randomized controlled trials.
trial registrationWHO International Clinical Trials Registry Platform, supported by the Korea Disease Control and Prevention Agency (KDCA): KCT0011412.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.